The most likely interpretation of these observations is that the invasive clone rarely develops from a lesion with a BRAF mutation, in line with the observation that the frequency of BRAF mutations in invasive lung adenocarcinomas is low (2−3%). This evidence concerns the gene BRAF and lung adenocarcinoma.